"The EuGeni SARS-CoV-2 Ag RDT has been registered in the European Community for the qualitative detection of SARS-CoV-2 antigen in nasopharyngeal specimens, following the requirements of IVDD 98/79/EC and obtaining the CE mark for its distribution in the European Community countries. Currently the product registration is in process in the United Kingdom with the Medicines and Healthcare products Regulatory Agency and Australia with the TGA (Therapeutic Goods Administration)."
So I guess we're still in the race in the UK.
ADO Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)